Latest News - Danaher
Top Corporates Hub
Danaher
DHR Q3 deep dive: execution focus and AI strategy underpin improved outlook
22.10.2026 08:14
Diversified science and technology company Danaher (NYSE:DHR) met Wall Street’s revenue expectations in Q3 2026, with sales up 8.3% year on year to $6.55 billion. Its non-GAAP profit of $2.11 per share was 10% above analysts’ consensus estimates.
Danaher (DHR) Stock Fair Value Edges Higher After Analysts Lift Targets
22.10.2026 04:26
Danaher is back in focus as analysts edge price targets into the US$240 to US$255 range, with some models now centering around fair value of about US$244.14. This shift reflects recent research that is divided between optimism on improving demand in life science tools and diagnostics, and concern that current valuations may already factor in a recovery, especially around bioprocessing. In the sections that follow, you will see how these updated targets fit into the broader narrative and what...
Danaher (DHR) Q3 2026 Earnings Call Transcript
21.10.2026 17:17
Revenue beat $6.6B with 8.5% growth; free cash flow hit $1.6B for the quarter.
Danaher Corporation Q3 2026 Earnings Call Summary
21.10.2026 16:57
Moby summary of Danaher Corporation's Q3 2026 earnings call
Danaher Jumps 4% on Q3 Beat: “Improving Trends” Across Its End Markets
21.10.2026 16:16
Danaher (DHR:NYSE) shares were up about 4% on Wednesday (trading at about $233) after the life sciences company beat third-quarter profit estimates and raised its full-year earnings guide. The stock opened about 3% lower before buyers took over.
Danaher Q3 Earnings Call Highlights
21.10.2026 15:04
Danaher (NYSE:DHR) reported third-quarter 2026 results that exceeded its expectations, citing improved market conditions, commercial execution and operational performance across its Biotechnology, Life Sciences and Diagnostics businesses. Sales totaled $6.6 billion for the quarter. Core revenue gro
DHR Q3 Earnings Beat on Biotechnology Strength, Sales in Line
21.10.2026 13:45
Danaher's third-quarter earnings beat estimates by 9.9%, driven by stronger Biotechnology profitability, while it raised its 2026 adjusted earnings outlook.
Strong Price Rally Validates Danaher’s (DHR) Undervalued Entry Point in Core Diagnostics Engine
21.10.2026 12:41
L1 Capital, an investment management firm, released its “L1 Capital International Fund” (unhedged) third-quarter 2026 investor letter. A copy of the letter can be downloaded here. This Quarterly Report covers the unusually complex investment environment, AI’s opportunities and challenges, portfolio strategy, September 2026 performance, and recent adjustments. The Fund returned +3.5% net of fees in […]
Danaher (DHR) Reports Q3 Earnings: What Key Metrics Have to Say
21.10.2026 12:30
Although the revenue and EPS for Danaher (DHR) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Danaher shares rise in premarket trade as Q3 earnings beat estimates
21.10.2026 10:41
Investing.com – Danaher Corporation (NYSE:DHR) shares rose in premarket trading on Wednesday after the life sciences and diagnostics company reported third-quarter adjusted earnings of $2.11 per share, beating analyst expectations of $1.92, while revenue climbed 8.5% year on year to $6.6 billion, topping estimates of $6.56 billion.
Danaher (DHR) Tops Q3 Earnings and Revenue Estimates
21.10.2026 10:25
Danaher (DHR) delivered earnings and revenue surprises of +9.90% and +0.10%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Healthcare and Life Sciences Leaders Build on NVIDIA to Advance Drug Discovery and Expand Patient Care
21.10.2026 10:13
Healthcare and Life Sciences Leader Build on NVIDIA NVIDIA today announced collaborations with leading global healthcare and research organizations to advance protein design — including through a newly released open model, RFD4-Proteina — accelerate drug discovery and bring greater precision to cancer care. News Summary: NVIDIA and the UW Medicine Institute for Protein Design debut RFD4-Proteina, a new open model that combines programmable protein design with search capabilities, unlocking new f
Danaher: Q3 Earnings Snapshot
21.10.2026 10:09
WASHINGTON (AP) — WASHINGTON (AP) — Danaher Corp. (DHR) on Wednesday reported third-quarter earnings of $1.
Danaher’s (NYSE:DHR) Q3 2026 Earnings Results: Revenue In Line With Expectations
21.10.2026 10:08
Diversified science and technology company Danaher (NYSE:DHR) met Wall Street’s revenue expectations in Q3 2026, with sales up 8.3% year on year to $6.55 billion. Its non-GAAP profit of $2.11 per share was 10% above analysts’ consensus estimates.
Danaher Reports Third Quarter 2026 Results
21.10.2026 10:00
Danaher Corporation (NYSE: DHR) today announced results for the third quarter 2026. All results in this release reflect only continuing operations and period-to-period comparisons are year-over-year unless otherwise noted.
Danaher Q3 2026 Earnings Call Transcript
21.10.2026 09:13
Danaher (NYSE:DHR) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For
Danaher Sees Q4 2026 Non-GAAP Core Revenue Excluding Respiratory Revenue Up 4%-5% YoY
21.10.2026 06:05
Danaher (NYSE:DHR) expects fourth quarter of 2026 non-GAAP core revenue, excluding respiratory revenue, to increase 4.0% to 5.0% year-over-year.
Danaher Raises FY2026 Adj EPS Guidance from $8.45-$8.60 to $8.57-$8.62 vs $8.51 Est
21.10.2026 06:02
Danaher (NYSE:DHR) raises FY2026 Adj EPS guidance from $8.45-$8.60 to $8.57-$8.62 vs $8.51 analyst estimate..
Danaher (DHR) Reports Q3: Everything You Need To Know Ahead Of Earnings
20.10.2026 08:13
Diversified science and technology company Danaher (NYSE:DHR) will be announcing earnings results this Wednesday morning. Here’s what to expect.
Roper Technologies (ROP) vs. Danaher (DHR): Which Is the Better Long-Term Capital Allocator?
18.10.2026 14:48
Roper Technologies, Inc. (NASDAQ:ROP) and Danaher Corporation (NYSE:DHR) have returned 4.01% and 18.97%, respectively, over the last six months, as of October 15. This compares to a 21.5% return for the Insider Monkey Billionaire Index and 15.74% for the State Street SPDR S&P 500 ETF Trust. Both have built their businesses around a similar idea: […]